Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Gynecol Oncol. 2015 Apr 16;138(1):24–29. doi: 10.1016/j.ygyno.2015.04.006

Figure 1.

Figure 1

Overall survival and progression-free survival. PFS: progression-free survival, mos: months Numbers at risk at time 0, 3, 6, 9, 12, 15, 18 and 21 months by endpoint are provided below the graph